MediWound Ltd. Ratios

Ratios Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin -975.29%-319.13%-38.51%36.78%38.61%62.73%34.67%36.91%49.69%19.15%13.03%
EBT Margin -53.36%-5,655.98%-3,107.99%-1,401.73%-582.25%-166.57%6.50%-42.62%-56.91%-73.68%-34.95%-149.16%
EBIT Margin -217.59%-8,272.97%-3,531.95%-1,293.65%-548.36%-116.44%14.13%-40.62%-47.22%-31.50%-81.83%-95.94%
EBITDA Margin -441.53%-7,282.24%-3,674.88%-1,211.68%-888.54%-30.70%15.61%-42.36%-56.94%-73.92%-36.01%-149.43%
Operating Margin -217.59%-8,272.97%-3,531.95%-1,293.65%-548.36%-116.44%14.13%-40.62%-47.22%-31.50%-81.83%-95.94%
Net Margin -196.61%-7,287.64%-69.38%-1,212.13%-305.13%135.49%9.09%0.37%-57.03%-73.97%-35.94%-149.46%
FCF Margin -224.08%-6,226.64%-3,323.96%-1,098.59%-701.12%-372.71%28.61%-35.92%-39.58%-46.95%-90.60%-98.39%
Efficiency
Inventory Average 1.57M1.28M1.36M1.78M1.65M1.50M1.29M1.58M2.40M2.77M
Assets Average 39.95M39.71M37.93M35.83M25.41M34.88M58.24M69.98M
Equity Average 33.17M15.62M8.57M9.17M12.07M11.22M1.34M3.17M21.25M31.37M
Invested Capital 42.87M23.47M7.77M9.37M8.97M15.17M7.27M-4.58M10.91M31.59M31.15M
Asset Utilization Ratio 0.060.090.840.610.940.760.320.29
Leverage & Solvency
Interest Coverage Ratio 2.2810.1414.19-15.87-10.93-1.871.51-6.91-4.85-0.72-8.08-1.51
Equity Ratio 0.220.210.250.370.23-0.230.220.480.42
Times Interest Earned 2.2810.1414.19-15.87-10.93-1.871.51-6.91-4.85-0.72-8.08-1.51
Valuation
Enterprise Value -7.05M110.44M141.54M71.19M83.39M99.10M77.01M83.27M53.26M44.61M81.89M177.95M
Market Capitalization 135.86M184.04M100.06M120.12M109.81M84.25M100.65M64.30M78.50M93.76M187.10M
Return Ratios
Return on Sales -1.97%-72.88%-0.69%-12.12%-3.05%1.35%0.09%0.00%-0.57%-0.74%-0.36%-1.49%
Return on Capital Employed -0.40%-0.11%0.16%-0.32%-0.76%-0.37%-0.38%-0.45%
Return on Assets -0.19%0.12%0.08%0.00%-0.53%-0.56%-0.12%-0.43%
Return on Equity -0.01%-1.21%-0.89%0.50%0.24%0.01%-10.08%-6.19%-0.32%-0.96%